Literature DB >> 20592549

Group B streptococcus: prevalence in a non-obstetric population.

Catherine M Leclair1, Ashley E Hart, Martha F Goetsch, Heather Carpentier, Jeffrey T Jensen.   

Abstract

OBJECTIVE: To establish and compare the prevalence of group B streptococcus (GBS) colonization in the vaginas of nonobstetric women with and without vaginitis.
MATERIALS AND METHODS: Cross-sectional analysis GBS vaginal culture status of nonpregnant, estrogen-replete women 18 years or older presenting for annual gynecological examinations or vaginal infection. Subjects were classified into 3 groups: no vaginitis if symptoms were absent and examination results was normal; common vaginitis (CV) if microscopic examination revealed yeast, bacterial vaginosis, or trichomonads; or inflammatory vaginitis (IV) if examination revealed inflammation and immature squamous cells but no pathogens.
RESULTS: Of the 215 women recruited, 147 (68.4%) showed no evidence of vaginitis, 41 (19.1%) had CV, and 27 (12.6%) showed evidence of IV. The overall prevalence rate of GBS was 22.8%. Vaginitis was associated with a significantly increased risk of GBS colonization (adjusted odds ratio: CV = 2.7, 95% CI = 1.1-6.2; IV = 2.9, 95% CI = 1.1-8.0). Logistic regression revealed pH higher than 4.5, presence of abnormal discharge on examination, and a women's complaint of current symptoms as significant predicators of the presence of GBS.
CONCLUSIONS: Group B streptococcus colonization occurs more commonly in women with vaginitis. This suggests that disruption of the normal vaginal bacterial environment is an important predictor for GBS colonization.

Entities:  

Mesh:

Year:  2010        PMID: 20592549      PMCID: PMC2898746          DOI: 10.1097/LGT.0b013e3181d3d40f

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  29 in total

1.  Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis.

Authors:  Gilbert G G Donders; Annie Vereecken; Eugene Bosmans; Alfons Dekeersmaecker; Geert Salembier; Bernard Spitz
Journal:  BJOG       Date:  2002-01       Impact factor: 6.531

2.  Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women.

Authors:  Leslie A Meyn; Donna M Moore; Sharon L Hillier; Marijane A Krohn
Journal:  Am J Epidemiol       Date:  2002-05-15       Impact factor: 4.897

3.  The prevalence of group B streptococci in human urogenital secretions.

Authors:  N E Jensen; B L Andersen
Journal:  Scand J Infect Dis       Date:  1979

4.  Anorectal and vaginal carriage of group B streptococci during pregnancy.

Authors:  H C Dillon; E Gray; M A Pass; B M Gray
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

5.  Vaginal colonization with group B streptococcus: a study in college women.

Authors:  C J Baker; D K Goroff; S Alpert; V A Crockett; S H Zinner; J R Evrard; B Rosner; W M McCormack
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

6.  Epidemiology of group B Streptococcus: longitudinal observations during pregnancy.

Authors:  B F Anthony; D M Okada; C J Hobel
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

7.  Predictive value of the clinical diagnosis of lower genital tract infection in women.

Authors:  Daniel V Landers; Harold C Wiesenfeld; R Phillip Heine; Marijane A Krohn; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2004-04       Impact factor: 8.661

Review 8.  Desquamative inflammatory vaginitis.

Authors:  Ruth Murphy
Journal:  Dermatol Ther       Date:  2004       Impact factor: 2.851

9.  Prevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women.

Authors:  Shannon D Manning; Katie Neighbors; Patricia A Tallman; Brenda Gillespie; Carl F Marrs; Stephanie M Borchardt; Carol J Baker; Mark D Pearlman; Betsy Foxman
Journal:  Clin Infect Dis       Date:  2004-07-16       Impact factor: 9.079

Review 10.  Evaluation of vaginal complaints.

Authors:  Matthew R Anderson; Kathleen Klink; Andreas Cohrssen
Journal:  JAMA       Date:  2004-03-17       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.